-

MetLife to Present New Frontier Strategy at December 12 Investor Day

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will hold an Investor Day in New York City on Thursday, December 12, 2024, at 8:30 a.m. (ET), where members of MetLife's executive leadership team and other senior leaders will present the company’s New Frontier strategy.

The Investor Day and accompanying presentation materials will include statements relating to the company’s business, operations, and financial results as well as certain projections regarding the company's future performance.

A live webcast of the event, along with the presentation materials, will be available at (http://www.metlife.com/InvestorDay2024). Those who want to access Investor Day should go to the web page at least 15 minutes prior to the event to register.

At the same website, a replay of the Investor Day will be available beginning shortly after the event ends on Thursday, December 12, 2024.

About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Contacts

For Media:
Dave Franecki
973-264-7465
Dave.Franecki@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

Industry:

MetLife, Inc.

NYSE:MET
Release Versions
English

Contacts

For Media:
Dave Franecki
973-264-7465
Dave.Franecki@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin’s offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common...

MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will s...

MetLife Appoints Two Experienced Leaders to Board of Directors

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the “Board”), effective immediately. Both leaders bring significant leadership and business experience to their roles. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as president and CEO of Mar...
Back to Newsroom